Delivery Order SPE2DB25D3108-SPE2DB25FPCZY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Brilinta 90 mg tablets (60-count units) at a ceiling value of $4,019.96. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The order is scheduled for completion by August 28, 2025, with the place of performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packages) on September 26, 2025, with a ceiling value of $1,642.85 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a pediatric or continuation order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $61,937.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Brilinta 90 mg tablets in a quantity of 60 units, with a ceiling value of $3,705.95. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $1,046.51. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement mechanism. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Brilinta 90 mg tablets in a 60-count quantity, with a ceiling value of $4,335.61. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive, competitively awarded transaction under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPCZYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen fulfills critical pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/2/25 |